Scott Keller joins as GC in July and will replace R. Hewitt Pate as CLO at the start of next year
Tina Hinz is elevated to GC and chief compliance officer role, succeeding Marc Merrill
Liesel Carvajal replaces Steve Stephan in the role
Sarah Karlgaard replaces GC Nancy Evert, who is leaving the business after more than two decades
Elizabeth Ryder returns to the role she vacated in 2022, replacing Rachel Morgan
Trudi Charles will join in August, replacing Isabelle Deschamps in the role
Aurimas Galdikas brings more than 15 years of financial markets experience to the role
Fernando Laguarda was most recently deputy GC at US federal agency GSA
Michael Green brings two decades of legal experience in the nuclear sector
Jake Eigner brought in to lead the 401(k) platform’s legal and regulatory strategy
Experienced trial lawyer Richard Coughlin replaces Rachelle Bin as GC
Chris Yang, who is currently SVP for enterprise strategy and solutions, will replace Sandra Phillips
Brian Heller will take over top lawyer role when Francis Poli retires next year
Elizabeth Moellering steps into the role vacated by John Martinez in February, who left to join Parsons
Adam Golden joins the drug-maker as it moves closer to becoming a publicly-traded company